Craneware

CRW · AIM · Health Care · mcap £374m · 1086.0p 1 open situation →

EV: £365m
EV / EBIT: 18.5x
Net cash: £8.5m
FCF yield: 4.9%
Revenue: £153m
Cash returned: 8.1%
Share price 1y: −54%
Insiders 12m: no deals
Next report: around 1 Mar

Craneware sells cloud software and data analytics, under the Trisus platform, that help US hospitals manage pricing, billing, drug-discount compliance and costs. Revenue is mostly recurring subscriptions.

Timeline · every situation

dots = announcements

20252026 Profit warning Profit upgrade Possible offer Results ahead of expectations

Open · 1

Upgrade / downgrade cycle

Profit warning

profit warning · second in 12 months

Craneware issued a profit warning on 21 Sep 2026; the shares moved −26% on the day. It is the second such statement in 12 months.

21 Sep 2026 profit warning · -26% on the day
3 Jul 2026 profit warning · -26% on the day

Open the full view – chart and every step →

Closed · 3

Upgrade / downgrade cycleProfit upgrade guidance raised · second in 12 months · 16 Jul 2025 – 14 Oct 2025 −13% Takeover targetPossible offer lapsed · 16 May 2025 – 11 Jun 2025 +2% Upgrade / downgrade cycleResults ahead of expectations ahead of expectations · 3 Sep 2024 – 2 Dec 2024 −12%

Company filings. Not investment advice.